Diabetic exposure and Liver cancer

Type2 diabetes and liver Cancer goes hand in hand with the mechanism and complications. The risk of liver cancer is higher in people with Type 2 Diabetes than people with Diabetes Type 1. An advance feasible natural instrument for the affiliation between diabetes and liver cancer is that up to 80% of individuals with diabetes type 2 are thought to have non-alcoholic fatty liver illness which increments hazard of cirrhosis and consequent Hepatocellular Carcinoma (HCC).

  • Metformin
  • Type 2 Diabetes
  • Non-alcoholic Fatty Liver Disease
  • Risk factors in Metabolic Irregularities

Related Conference of Diabetic exposure and Liver cancer

June 01-02, 2026

2nd International Congress on Primary Health and Safety

Zurich, Switzerland
June 15-16, 2026

8th World Conference on Vaccine and Immunology

Paris, France
July 06-07, 2026

14th International conference on Liver and Hepatitis

Barcelona, Spain
July 13-14, 2026

13th World congress on Hospice and Palliative care

Amsterdam, Netherlands
July 23-24, 2026

37th European Heart and Heart Failure Congress

Paris, France
August 27-28, 2026

22nd Global Biomarkers and Clinical Research Summit

Paris, France
September 28-29, 2026

13th International Conference on Stroke and Neurological Disorders

Amsterdam, Netherlands
October 19-20, 2026

6th Euro-Global Summit on Probiotics & Nutraceuticals

Paris, France
November 16-17, 2026

11th Global Summit on Midwifery and Womens Health

Tokyo, Japan
December 16-17, 2026

7th Global Summit on Public Health

Amsterdam, Netherlands

Diabetic exposure and Liver cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in